참고문헌 (23)

1. Eur. J. Med. Chem. Raghavendra 143 1277 2018 10.1016/j.ejmech.2017.10.021 Dual or multi-targeting inhibitors: The next generation anticancer agents 

   상세보기

2. Sci. Rep. Karaman 6 31566 2016 10.1038/srep31566 Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice 

   상세보기

3. Mol. Metab. Karaman 4 2 93 2015 10.1016/j.molmet.2014.11.006 Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet 

   상세보기

4. Mol. Cell Endocrinol. Kim 358 1 127 2012 10.1016/j.mce.2012.03.013 Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice 

   상세보기

5. Lancet Gerstein 368 9541 1096 2006 10.1016/S0140-6736(06)69420-8 Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial 

   상세보기

6. Molecules Colin-Lozano 23 2 2018 10.3390/molecules23020340 Design, synthesis and in combo antidiabetic bioevaluation of multitarget phenylpropanoic acids 

   상세보기

7. Drugs R D. Vuylsteke 15 3 227 2015 10.1007/s40268-015-0099-3 Imeglimin: a potential new multi-target drug for type 2 diabetes 

   상세보기

8. Curr. Opin. Drug. Discov. Devel. Tobin 5 4 500 2002 Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes 

   상세보기

9. Nat. Rev. Drug. Discov. Crunkhorn 16 5 312 2017 10.1038/nrd.2017.73 Metabolic disease: protein tyrosine phosphatase inhibitor reverses diabetes 

   상세보기

10. Acta. Pharmacol. Sin. He 35 10 1227 2014 10.1038/aps.2014.80 Protein tyrosine phosphatases as potential therapeutic targets 

    상세보기

11. Discov. Med. Bowden 4 24 427 2004 Association of the PTPN1 gene with type 2 diabetes and insulin resistance 

    상세보기

12. CellMetab. Cho 3 5 367 2006 Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling 

13. Biochim. Biophys. Acta. Hendriks 1832 10 1673 2013 10.1016/j.bbadis.2013.05.022 Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities 

    상세보기

14. J. Am. Chem. Soc. Zhang 134 43 18116 2012 10.1021/ja308212y A highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes 

    상세보기

15. J. Biol. Chem. Xu 278 32 30187 2003 10.1074/jbc.M302010200 Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance 

    상세보기

16. Biochem. Biophys. Res. Commun. Cho 467 2 211 2015 10.1016/j.bbrc.2015.10.004 Phosphoprotein phosphatase 1CB (PPP1CB), a novel adipogenic activator, promotes 3T3-L1 adipogenesis 

    상세보기

17. Chemistry Lee 17 1 143 2011 10.1002/chem.201002560 Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells 

    상세보기

18. Pharmacol. Res. Lee 119 422 2017 10.1016/j.phrs.2017.03.003 Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis 

    상세보기

19. Acta. Physiol. (Oxf) Zhou 196 1 175 2009 10.1111/j.1748-1716.2009.01967.x AMPK activators-potential therapeutics for metabolic and other diseases 

    상세보기

20. Oncotarget Ma 6 25 20993 2015 10.18632/oncotarget.3663 Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis 

    상세보기

21. Chemotherapy Zhou 56 5 393 2010 10.1159/000317750 Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis 

    상세보기

22. Curr. Diabetes Rev. Bouzakri 1 2 167 2005 10.2174/1573399054022785 Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes 

    

23. Nature Rosen 444 7121 847 2006 10.1038/nature05483 Adipocytes as regulators of energy balance and glucose homeostasis 

    상세보기